Amdocs Limited $DOX Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp decreased its stake in Amdocs Limited (NASDAQ:DOX) by 2.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 642,565 shares of the technology company’s stock after selling 16,462 shares during the period. Boston Trust Walden Corp owned approximately 0.60% of Amdocs worth $41,934,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. WealthCollab LLC grew its holdings in Amdocs by 94.5% during the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after purchasing an additional 173 shares in the last quarter. BOK Financial Private Wealth Inc. purchased a new position in shares of Amdocs during the 4th quarter valued at approximately $37,000. Los Angeles Capital Management LLC acquired a new stake in shares of Amdocs during the fourth quarter worth approximately $39,000. Advisory Services Network LLC acquired a new stake in shares of Amdocs during the third quarter worth approximately $42,000. Finally, CIBC Private Wealth Group LLC increased its stake in shares of Amdocs by 190.2% in the third quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company’s stock worth $49,000 after buying an additional 390 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on DOX shares. Cfra cut shares of Amdocs to a “sell” rating in a report on Thursday, May 14th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Stifel Nicolaus reduced their price target on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Finally, KeyCorp began coverage on Amdocs in a research note on Monday. They issued a “sector weight” rating for the company. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $86.67.

Key Amdocs News

Here are the key news stories impacting Amdocs this week:

• Neutral Sentiment: KeyCorp reiterated a “Sector Weight” rating on Amdocs and published quarterly earnings estimates that are mostly in line with current expectations, including FY2026 EPS of $6.54 versus consensus of $6.56.
• Neutral Sentiment: The firm’s FY2027 EPS estimate of $7.02 suggests modest expected earnings growth, which may help support sentiment, but the update does not appear materially more bullish than the market already expected.
• Neutral Sentiment: Additional posts referenced Amdocs in broad “cheap stocks” and short-interest content, but those items do not appear to include new company-specific fundamentals likely driving the stock today. Article Title

Amdocs Stock Performance

DOX stock opened at $51.75 on Friday. The stock’s 50 day simple moving average is $59.39 and its 200 day simple moving average is $68.30. Amdocs Limited has a 12-month low of $49.79 and a 12-month high of $93.44. The firm has a market cap of $5.59 billion, a P/E ratio of 10.35, a P/E/G ratio of 0.89 and a beta of 0.41. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Thursday, May 14th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The firm had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. As a group, equities research analysts predict that Amdocs Limited will post 6.56 EPS for the current year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.28 annualized dividend and a dividend yield of 4.4%. Amdocs’s dividend payout ratio (DPR) is 45.60%.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.